Dassault Systemes Aktie
| 24,54EUR | -0,05EUR | -0,20% |
WKN DE: A3CRC5 / ISIN: FR0014003TT8
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 19 789 | 20 496 | 22 523 | 23 811 | 25 000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,22 | 0,24 | 0,25 | 0,25 | 0,25 |
Bilanz (in Mio. EUR) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 3 735 | 4 684 | 4 802 | 5 736 | 6 516 |
| Summe Anlagevermögen | 9 229 | 9 535 | 9 459 | 8 887 | 9 030 |
| Summe Aktiva | 12 964 | 14 219 | 14 261 | 14 623 | 15 546 |
Bilanz (in Mio. EUR) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 7 858 | 8 008 | 6 936 | 6 777 | 6 465 |
| Summe Eigenkapital | 5 106 | 6 211 | 7 325 | 7 846 | 9 081 |
| Summe Passiva | 12 964 | 14 219 | 14 261 | 14 623 | 15 546 |
Adresse
| 10, rue Marcel Dassault, 78140 Vélizy-Villacoublay | |
| Telefon | +33 (1) 61-62-61-62 |
| Internet | http://www.3ds.com |
Management
|
Anne Asensio
Vice President-Design Experience |
|
Anthony J. Costello
President-Patient Cloud |
|
Bernard Charlès
Executive Chairman |
|
Bruno Latchague
Senior EVP-Global Field American Operations |
|
Béatrix Martinez
Vice President-Investor Relations |
|
Catherine Dassault
Director |
|
Claire Biot
Vice President-Life Sciences Industry |
|
Dominique Florack
President |
|
Elisa Prisner
Executive VP-Industry, Marketing & Sustainability |
|
Florence Hu Aubigny
Executive Vice President-Research & Development |
|
Florence Verzelen
EVP-Industry, Marketing & Sustainability |
|
Geneviéve B. Berger
Independent Non-Executive Director |
|
Grégory Abate
Secretary & Senior Executive Vice President |
|
Herve Andorre
Director |
|
Laurence Barthès
Executive VP, Chief People & Information Officer |
|
Laurence Daures-Lescourret
Lead Independent Director |
|
Marie-Hélène Habert-Dassault
Director |
|
Odile Desforges
Independent Director |
|
Olivier Ribet
Executive Vice President |
|
Pascal Daloz
Chief Executive Officer & Director |
|
Philippe Laufer
Executive Vice-President-Global Brands |
|
Rouven Bergmann
Chief Financial Officer & Executive Vice President |
|
Soumitra Dutta
Independent Director |
|
Stéphane Declée
Chief Executive Officer-ENOVIA |
|
Tanneguy de Fromont de Bouaille
Director |
|
Tarek A. Sherif
Chairman-Life Sciences & Healthcare |
|
Victoire de Margerie
VP-Corporate Equity, Marketing & Communications |
|
Xavier Cauchois
Independent Director |